# FOXA1

## Overview
FOXA1, or forkhead box A1, is a gene that encodes the FOXA1 protein, a transcription factor belonging to the forkhead family characterized by a winged-helix DNA-binding domain. This protein plays a pivotal role in chromatin remodeling and gene regulation, acting as a pioneer factor that facilitates the binding of other transcription factors by opening chromatin regions (Ravi2024Towards; Paranjapye2020The). FOXA1 is crucial for maintaining epithelial cell identity and function, particularly in the context of epithelial-mesenchymal transition and epithelial barrier integrity (Paranjapye2020The). It is involved in various cellular processes, including cell adhesion and migration, and interacts with several proteins and nucleic acids to regulate gene expression (Sun2009Upstream; Paranjapye2020The). Clinically, FOXA1 mutations are significant in hormone-dependent cancers such as prostate and breast cancer, where they influence disease progression and treatment response (Liu2024FOXA1; Abeshouse2015The).

## Structure
FOXA1 is a transcription factor characterized by a winged-helix DNA-binding domain, which is part of its secondary structure. This domain is highly conserved and consists of three alpha-helices, three beta-sheets, and two large loops, known as 'wing' regions, that flank the third beta-sheet (Jackson2010Update). The DNA-binding domain of FOXA1 is similar to the helix-turn-helix structure, allowing it to interact with nucleosomes and DNA, facilitating chromatin remodeling (Ravi2024Towards).

The FOXA1 protein is predominantly unstructured, with over 73% being random coil, 13% alpha-helices, and the rest extended strands, indicating a propensity for instability (Ravi2024Towards). The C-terminal domain of FOXA1 interacts with histones H3 and H4, playing a role in chromatin accessibility and transcription regulation (Jackson2010Update; Ravi2024Towards).

FOXA1 can exist in different isoforms due to alternative splicing, although specific details on these isoforms are not provided in the context. The protein may undergo post-translational modifications, such as phosphorylation, which can affect its activity and interactions, although specific modifications are not detailed in the provided context.

## Function
FOXA1 is a transcription factor that plays a critical role in maintaining epithelial cell identity and function in healthy human cells. It is involved in the regulation of gene expression related to epithelial barrier function and epithelial-mesenchymal transition (EMT), which are essential for maintaining lung health (Paranjapye2020The). FOXA1 represses genes associated with mesodermal and mesenchymal differentiation pathways, thereby preserving epithelial characteristics (Paranjapye2020The). It is a pioneer factor capable of opening chromatin regions, facilitating the binding of other transcription factors and regulating gene expression (Paranjapye2020The).

In the context of lung epithelial cells, FOXA1 is crucial for processes such as cell adhesion, extracellular matrix organization, and cell migration, which are vital for epithelial integrity and morphogenesis (Paranjapye2020The). Depletion of FOXA1 impairs epithelial integrity, as evidenced by a decrease in trans-epithelial resistance, highlighting its role in maintaining the epithelial barrier (Paranjapye2020The).

FOXA1 is also involved in the transcriptional network of primary human airway epithelial cells, where it coordinates key functions and influences the expression of other transcription factors like SPDEF and HOPX1 (Paranjapye2020The). This regulatory network is not limited to a single cell type, as FOXA1 is expressed in the majority of cell types in human bronchial epithelial cultures (Paranjapye2020The).

## Clinical Significance
Mutations and alterations in the FOXA1 gene have significant clinical implications in various cancers, particularly hormone-dependent ones like prostate and breast cancer. In prostate cancer, FOXA1 mutations are recurrent, occurring in about 3-5% of cases, and are associated with changes in androgen receptor (AR) signaling and chromatin remodeling. These mutations can lead to enhanced pioneer factor activity, promoting epithelial-mesenchymal transition (EMT) and metastasis, which are linked to poor prognosis (Teng2020Pioneer; Abeshouse2015The). FOXA1 mutations also result in significant alterations in gene expression and signaling pathways, affecting cancer progression and treatment responses (Hwang2023Unveiling).

In breast cancer, FOXA1 mutations are common in estrogen receptor-positive cases and can alter its function, impacting endocrine therapy sensitivity. These mutations are associated with lower progression-free survival after aromatase inhibitor treatment and contribute to drug resistance by regulating downstream gene expression (Liu2024FOXA1). Additionally, FOXA1 overexpression is linked to oncogenic signatures and proteomic changes associated with endocrine resistance (Liu2024FOXA1).

FOXA1 mutations are also implicated in extramammary Paget's disease (EMPD), where they are prevalent and may contribute to disease pathogenesis through altered gene expression and interactions (Takeichi2020Frequent).

## Interactions
FOXA1 interacts with various proteins and nucleic acids, playing a significant role in gene regulation. In prostate-specific gene expression, FOXA1 interacts with the transcription factor USF2. This interaction occurs at overlapping binding sites in androgen response regions, such as the PSA core enhancer and the PB and SBP promoters. The interaction between FOXA1 and USF2 is mediated by their respective DNA-binding domains, and it does not require DNA presence, as confirmed by coimmunoprecipitation experiments (Sun2009Upstream).

In breast cancer, FOXA1 interacts with cyclin-dependent kinase 1 (CDK1), potentially regulating FOXA1 through phosphorylation. This interaction is significant in HER2 positive cell lines, where kinases like PI3K and mTOR influence FOXA1's chromatin binding (Wang2018High).

FOXA1 also interacts with the androgen receptor (AR) to regulate gene expression in the prostate and epididymis. This interaction involves protein-protein binding without direct DNA interaction, forming a DNA/AR/FOXA complex (YU2005Foxa1).

In the context of the p27 Kip1 promoter, FOXA1 can activate transcription alone and synergistically with BRCA1. This interaction is crucial for the transcriptional regulation of the p27 Kip1 promoter (Williamson2005BRCA1).


## References


[1. (YU2005Foxa1) XIUPING YU, APARNA GUPTA, YONGQING WANG, KICHIYA SUZUKI, JANNI MIROSEVICH, MARIE‐CLAIRE ORGEBIN‐CRIST, and ROBERT J. MATUSIK. Foxa1 and foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Annals of the New York Academy of Sciences, 1061(1):77–93, December 2005. URL: http://dx.doi.org/10.1196/annals.1336.009, doi:10.1196/annals.1336.009. This article has 80 citations and is from a peer-reviewed journal.](https://doi.org/10.1196/annals.1336.009)

[2. (Williamson2005BRCA1) E A Williamson, I Wolf, J O’Kelly, S Bose, S Tanosaki, and H P Koeffler. Brca1 and foxa1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27kip1. Oncogene, 25(9):1391–1399, December 2005. URL: http://dx.doi.org/10.1038/sj.onc.1209170, doi:10.1038/sj.onc.1209170. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1209170)

[3. (Jackson2010Update) Brian C. Jackson, Christopher Carpenter, Daniel W. Nebert, and Vasilis Vasiliou. Update of human and mouse forkhead box (fox) gene families. Human Genomics, June 2010. URL: http://dx.doi.org/10.1186/1479-7364-4-5-345, doi:10.1186/1479-7364-4-5-345. This article has 185 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1479-7364-4-5-345)

[4. (Hwang2023Unveiling) Kyung Won Hwang, Jae Won Yun, and Hong Sook Kim. Unveiling the molecular landscape of foxa1 mutant prostate cancer: insights and prospects for targeted therapeutic strategies. International Journal of Molecular Sciences, 24(21):15823, October 2023. URL: http://dx.doi.org/10.3390/ijms242115823, doi:10.3390/ijms242115823. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms242115823)

[5. (Takeichi2020Frequent) Takuya Takeichi, Yusuke Okuno, Takaaki Matsumoto, Nobuyuki Tsunoda, Kyogo Suzuki, Kana Tanahashi, Michihiro Kono, Toyone Kikumori, Yoshinao Muro, and Masashi Akiyama. Frequent foxa1-activating mutations in extramammary paget’s disease. Cancers, 12(4):820, March 2020. URL: http://dx.doi.org/10.3390/cancers12040820, doi:10.3390/cancers12040820. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers12040820)

[6. (Abeshouse2015The) Adam Abeshouse, Jaeil Ahn, Rehan Akbani, Adrian Ally, Samirkumar Amin, Christopher D. Andry, Matti Annala, Armen Aprikian, Joshua Armenia, Arshi Arora, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Christopher E. Barbieri, Thomas Bauer, Christopher C. Benz, Alain Bergeron, Rameen Beroukhim, Mario Berrios, Adrian Bivol, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Rodolfo Borges dos Reis, Paul C. Boutros, Jay Bowen, Reanne Bowlby, Jeffrey Boyd, Robert K. Bradley, Anne Breggia, Fadi Brimo, Christopher A. Bristow, Denise Brooks, Bradley M. Broom, Alan H. Bryce, Glenn Bubley, Eric Burks, Yaron S.N. Butterfield, Michael Button, David Canes, Carlos G. Carlotti, Rebecca Carlsen, Michel Carmel, Peter R. Carroll, Scott L. Carter, Richard Cartun, Brett S. Carver, June M. Chan, Matthew T. Chang, Yu Chen, Andrew D. Cherniack, Simone Chevalier, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Matthew R. Cooperberg, Niall M. Corcoran, Anthony J. Costello, Janet Cowan, Daniel Crain, Erin Curley, Kerstin David, John A. Demchok, Francesca Demichelis, Noreen Dhalla, Rajiv Dhir, Alexandre Doueik, Bettina Drake, Heidi Dvinge, Natalya Dyakova, Ina Felau, Martin L. Ferguson, Scott Frazer, Stephen Freedland, Yao Fu, Stacey B. Gabriel, Jianjiong Gao, Johanna Gardner, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Mark B. Gerstein, Gad Getz, Andrew K. Godwin, Anuradha Gopalan, Markus Graefen, Kiley Graim, Thomas Gribbin, Ranabir Guin, Manaswi Gupta, Angela Hadjipanayis, Syed Haider, Lucie Hamel, D. Neil Hayes, David I. Heiman, Julian Hess, Katherine A. Hoadley, Andrea H. Holbrook, Robert A. Holt, Antonia Holway, Christopher M. Hovens, Alan P. Hoyle, Mei Huang, Carolyn M. Hutter, Michael Ittmann, Lisa Iype, Stuart R. Jefferys, Corbin D. Jones, Steven J.M. Jones, Hartmut Juhl, Andre Kahles, Christopher J. Kane, Katayoon Kasaian, Michael Kerger, Ekta Khurana, Jaegil Kim, Robert J. Klein, Raju Kucherlapati, Louis Lacombe, Marc Ladanyi, Phillip H. Lai, Peter W. Laird, Eric S. Lander, Mathieu Latour, Michael S. Lawrence, Kevin Lau, Tucker LeBien, Darlene Lee, Semin Lee, Kjong-Van Lehmann, Kristen M. Leraas, Ignaty Leshchiner, Robert Leung, John A. Libertino, Tara M. Lichtenberg, Pei Lin, W. Marston Linehan, Shiyun Ling, Scott M. Lippman, Jia Liu, Wenbin Liu, Lucas Lochovsky, Massimo Loda, Christopher Logothetis, Laxmi Lolla, Teri Longacre, Yiling Lu, Jianhua Luo, Yussanne Ma, Harshad S. Mahadeshwar, David Mallery, Armaz Mariamidze, Marco A. Marra, Michael Mayo, Shannon McCall, Ginette McKercher, Shaowu Meng, Anne-Marie Mes-Masson, Maria J. Merino, Matthew Meyerson, Piotr A. Mieczkowski, Gordon B. Mills, Kenna R. Mills Shaw, Sarah Minner, Alireza Moinzadeh, Richard A. Moore, Scott Morris, Carl Morrison, Lisle E. Mose, Andrew J. Mungall, Bradley A. Murray, Jerome B. Myers, Rashi Naresh, Joel Nelson, Mark A. Nelson, Peter S. Nelson, Yulia Newton, Michael S. Noble, Houtan Noushmehr, Matti Nykter, Angeliki Pantazi, Michael Parfenov, Peter J. Park, Joel S. Parker, Joseph Paulauskis, Robert Penny, Charles M. Perou, Alain Piché, Todd Pihl, Peter A. Pinto, Davide Prandi, Alexei Protopopov, Nilsa C. Ramirez, Arvind Rao, W. Kimryn Rathmell, Gunnar Rätsch, Xiaojia Ren, Victor E. Reuter, Sheila M. Reynolds, Suhn K. Rhie, Kimberly Rieger-Christ, Jeffrey Roach, A. Gordon Robertson, Brian Robinson, Mark A. Rubin, Fred Saad, Sara Sadeghi, Gordon Saksena, Charles Saller, Andrew Salner, Francisco Sanchez-Vega, Chris Sander, George Sandusky, Guido Sauter, Andrea Sboner, Peter T. Scardino, Eleonora Scarlata, Jacqueline E. Schein, Thorsten Schlomm, Laura S. Schmidt, Nikolaus Schultz, Steven E. Schumacher, Jonathan Seidman, Luciano Neder, Sahil Seth, Alexis Sharp, Candace Shelton, Troy Shelton, Hui Shen, Ronglai Shen, Mark Sherman, Margi Sheth, Yan Shi, Juliann Shih, Ilya Shmulevich, Jeffry Simko, Ronald Simon, Janae V. Simons, Payal Sipahimalani, Tara Skelly, Heidi J. Sofia, Matthew G. Soloway, Xingzhi Song, Andrea Sorcini, Carrie Sougnez, Serghei Stepa, Chip Stewart, John Stewart, Joshua M. Stuart, Travis B. Sullivan, Charlie Sun, Huandong Sun, Angela Tam, Donghui Tan, Jiabin Tang, Roy Tarnuzzer, Katherine Tarvin, Barry S. Taylor, Patrick Teebagy, Imelda Tenggara, Bernard Têtu, Ashutosh Tewari, Nina Thiessen, Timothy Thompson, Leigh B. Thorne, Daniela P. Tirapelli, Scott A. Tomlins, Felipe Amstalden Trevisan, Patricia Troncoso, Lawrence D. True, Maria Christina Tsourlakis, Svitlana Tyekucheva, Eliezer Van Allen, David J. Van Den Berg, Umadevi Veluvolu, Roel Verhaak, Cathy D. Vocke, Doug Voet, Yunhu Wan, Qingguo Wang, Wenyi Wang, Zhining Wang, Nils Weinhold, John N. Weinstein, Daniel J. Weisenberger, Matthew D. Wilkerson, Lisa Wise, John Witte, Chia-Chin Wu, Junyuan Wu, Ye Wu, Andrew W. Xu, Shalini S. Yadav, Liming Yang, Lixing Yang, Christina Yau, Huihui Ye, Peggy Yena, Thomas Zeng, Jean C. Zenklusen, Hailei Zhang, Jianhua Zhang, Jiashan Zhang, Wei Zhang, Yi Zhong, Kelsey Zhu, and Erik Zmuda. The molecular taxonomy of primary prostate cancer. Cell, 163(4):1011–1025, November 2015. URL: http://dx.doi.org/10.1016/j.cell.2015.10.025, doi:10.1016/j.cell.2015.10.025. This article has 2191 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2015.10.025)

[7. (Paranjapye2020The) Alekh Paranjapye, Michael J. Mutolo, Jey Sabith Ebron, Shih-Hsing Leir, and Ann Harris. The foxa1 transcriptional network coordinates key functions of primary human airway epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology, 319(1):L126–L136, July 2020. URL: http://dx.doi.org/10.1152/ajplung.00023.2020, doi:10.1152/ajplung.00023.2020. This article has 24 citations.](https://doi.org/10.1152/ajplung.00023.2020)

8. (Ravi2024Towards) Towards X-ray crystallographic characterization of nucleosome interactions with linker histones, FOXA proteins and high mobility group N factors. This article has 0 citations.

[9. (Liu2024FOXA1) Na Liu, Anran Wang, Mengen Xue, Xiaoren Zhu, Yang Liu, and Minbin Chen. Foxa1 and foxa2: the regulatory mechanisms and therapeutic implications in cancer. Cell Death Discovery, April 2024. URL: http://dx.doi.org/10.1038/s41420-024-01936-1, doi:10.1038/s41420-024-01936-1. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-024-01936-1)

[10. (Teng2020Pioneer) Mona Teng, Stanley Zhou, Changmeng Cai, Mathieu Lupien, and Housheng Hansen He. Pioneer of prostate cancer: past, present and the future of foxa1. Protein &amp; Cell, 12(1):29–38, September 2020. URL: http://dx.doi.org/10.1007/s13238-020-00786-8, doi:10.1007/s13238-020-00786-8. This article has 91 citations.](https://doi.org/10.1007/s13238-020-00786-8)

[11. (Sun2009Upstream) Qian Sun, Xiuping Yu, David J. Degraff, and Robert J. Matusik. Upstream stimulatory factor 2, a novel foxa1-interacting protein, is involved in prostate-specific gene expression. Molecular Endocrinology, 23(12):2038–2047, December 2009. URL: http://dx.doi.org/10.1210/me.2009-0092, doi:10.1210/me.2009-0092. This article has 19 citations.](https://doi.org/10.1210/me.2009-0092)

[12. (Wang2018High) Shixiong Wang, Sachin Kumar Singh, Madhumohan R. Katika, Sandra Lopez-Aviles, and Antoni Hurtado. High throughput chemical screening reveals multiple regulatory proteins on foxa1 in breast cancer cell lines. International Journal of Molecular Sciences, 19(12):4123, December 2018. URL: http://dx.doi.org/10.3390/ijms19124123, doi:10.3390/ijms19124123. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms19124123)